Video 6: Why Avilamycin is the responsible choice; WHO guidelines
Why Avilamycin is the Responsible Choice; WHO Guidelines

Video 6: Why Avilamycin is the responsible choice; WHO guidelines

Integrity Corner
16-02-2022 | |
Video 6: Why Avilamycin is the responsible choice; WHO guidelines
Why Avilamycin is the Responsible Choice; WHO Guidelines

In this 6th video, we will learn about WHO guidelines on animal use of medically important antimicrobials and why Avilamycin is the responsible choice.

In this episode, we will learn why Avilamycin is the responsible choice and WHO guidelines on animal use of medically important antimicrobials.

In 2017, the World Health Organization (WHO) published the Guidelines on use of Medically Important Antimicrobials in Food-Producing Animals. The objective of these guidelines is risk management of antimicrobial resistance due to non-human use.

The antimicrobials used should start with those of least importance for human health, e.g., start with classes not used in humans, and then as listed on the WHO CIA List.

Antimicrobials classified as critically important in human medicine on the WHO CIE List should be used only when the most recent culture and sensitivity results of bacteria know to have caused the disease indicate that the critically important antimicrobial is the only option.

2 important documents – The Ranking of MIA and Guidelines for Use of MIA and Food-Producing Animals – are available for use by policy-makers and government officials as well as veterinarians and livestock keepers as guidelines for responsible antimicrobial use.

Key learnings:

  • Antimicrobial classes not used in humans = ‘Animal only
  • Responsible use starts with ‘Animal only’ antimicrobials (e.g., Avilamycin)
  • Avilamycin is the first-choice antimicrobial for necrotic enteritis control
  • Choosing Avilamycin helps reduce the poultry industry’s reliance on medicines that are important for human health

Take a look at the previous 3 videos from the series

Join 31,000+ subscribers

Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.
More about
Integrity Corner
Intestinal Integrity Corner Company profile

Intestinal Integrity Corner, produced by Elanco, brings you insights into threats to broiler gut health and how to mitigate them with strategies for prevention, management and disease treatment that reduce reliance on medically important antibiotics. Elanco is committed to the poultry industry, delivering important scientific information about Intestinal Integrity, technical expertise, customer support and proven products such as Maxiban and Monteban. Maxiban and Monteban together form a trusted solution to maintain optimal enteric health resulting in efficient, healthy birds to promote safer food, better economic return and more brand assurance. Elanco is a global animal health company that develops products and knowledge services to prevent and treat disease in farm animals and pets in more than 90 countries. Elanco creates innovative solutions through products and services that address the challenges of an ever-changing world and empower those who raise and care for animals. Visit the Elanco website for more information  

Integrity Corner
Intestinal Integrity Corner Company profile

Intestinal Integrity Corner, produced by Elanco, brings you insights into threats to broiler gut health and how to mitigate them with strategies for prevention, management and disease treatment that reduce reliance on medically important antibiotics. Elanco is committed to the poultry industry, delivering important scientific information about Intestinal Integrity, technical expertise, customer support and proven products such as Maxiban and Monteban. Maxiban and Monteban together form a trusted solution to maintain optimal enteric health resulting in efficient, healthy birds to promote safer food, better economic return and more brand assurance. Elanco is a global animal health company that develops products and knowledge services to prevent and treat disease in farm animals and pets in more than 90 countries. Elanco creates innovative solutions through products and services that address the challenges of an ever-changing world and empower those who raise and care for animals. Visit the Elanco website for more information  

Beheer